InvestorsHub Logo
Followers 56
Posts 14300
Boards Moderated 0
Alias Born 01/19/2009

Re: Ubertino post# 136176

Friday, 11/17/2017 2:29:37 PM

Friday, November 17, 2017 2:29:37 PM

Post# of 146201
Not even close.

First NNVC didn't receive $5M from Boniuk. Rather, Boniuk redeemed his Series C Convertable Debenture for a shitload of common shares he will likely dump before they become worthless. You can read about it here:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136209926


Second, the redemption of Boniuk's debenture was completed prior to the release of the 10-Q. That is, these words written by Seymour describe NNVC's current financial situation after Boniuk already redeemed his debenture:


Management believes that the Company’s existing cash resources are sufficient for its operations at the current rate of expenditures to continue through November 2018. However, management believes that the available funds are insufficient for the Company’s projected work, which is beyond normal pre-clinical development operations, leading towards an Investigational New Drug Application (IND) filing with the U.S. Food and Drug Administration (FDA), to continue through November 2018.
p.10 https://ih.advfn.com/p.php?pid=nmona&article=76095857




A casual stroll through the lunatic asylum shows that faith does not prove anything. Friedrich Nietzsche

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News